Pay in 4 interest-free payments of $7.30 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Here, we'll tackle a few more key questions to help guide your wellness journey
doi: 10.1159/000521264 Summary Keywords GLP-1R agonists, obesity, weight-reducing drugs, metabolic diseases, dual agonism Citation Wang J-Y, Wang Q-W, Yang X-Y, Yang W, Li D-R, Jin J-Y, Zhang H-C and Zhang X-F (2023) GLP1 receptor agonists for the treatment of obesity: Role as a promising approach
Obesity-associated melanocortin-4 receptor mutations are associated with changes in the brain response to food cues
Associations between vascular endothelial growth factor gene polymorphisms and susceptibility to acute mountain sickness
US$ 23.63
US$ 29.71
US$ 26.18
US$ 21.77
